0001853816
EX-FILING FEES
0001853816
2026-01-22
2026-01-22
0001853816
1
2026-01-22
2026-01-22
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
EXHIBIT
107
Calculation
of Filing Fee Tables
Form
S-3
(Form
Type)
Dermata
Therapeutics, Inc.
(Exact
Name of Registrant as Specified in its Charter)
| | |
Security Type | |
Security
Class
Title | |
Fee Calculation or
Carry Forward Rule | |
Amount Registered
(1) | | |
Proposed Maximum Offering Price
Per Unit
(2) | | |
Maximum
Aggregate
Offering Price
(1) | | |
Fee
Rate | | |
Amount
of Registration Fee | |
| Fees
to Be Paid | |
Equity | |
Common Stock, par value $0.0001
per share | |
Other | |
| 6,207,730 | | |
$ | 2.08 | | |
$ | 12,912,078.40 | | |
| 0.00013810 | | |
$ | 1,783.16 | |
| | |
Total
Offering Amounts | |
| | | |
| | | |
$ | 12,912,078.40 | | |
| | | |
$ | 1,783.16 | |
| | |
Total
Fees Previously Paid | |
| | | |
| | | |
| | | |
| | | |
$ | 0 | |
| | |
Total
Fee Offsets | |
| | | |
| | | |
| | | |
| | | |
$ | 0 | |
| | |
Net
Fee Due | |
| | | |
| | | |
| | | |
| | | |
$ | 1,783.16 | |
| (1) |
Pursuant to Rule 416 under
the Securities Act of 1933, as amended (the “Securities Act”), there is also being registered hereby such indeterminate
number of additional common shares as may be issued or issuable because of stock splits, stock dividends stock distributions, and
similar transactions. |
| |
|
| (2) |
Estimated solely for the
purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based on a per share price of $2.08,
the average of the high $2.15 and low $2.01 reported sales prices of the registrant’s common stock on the Nasdaq Capital
Market on January 21, 2026. |
N/A